- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06044064
"Effect of Screening Using Imaging (CT/ EUS) on Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in Patients With New Onset Diabetes (NOD)" - A Prospective Pilot Observational Study
To assess whether EUS (Endoscopic Ultrasound) can serve as a valuable diagnostic tool for identifying PDAC at an early stage in individuals who have recently been diagnosed with diabetes.
Purpose: To improve the rates of early detection of pancreatic cancer.
Pancreatic ductal adenocarcinoma (PDAC) is a type of cancer that starts in the pancreas, a gland located in your abdomen. It happens when some cells in the pancreas start growing abnormally and form a cancer.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age > 50 years
- Patients diagnosed with diabetes based on FBS/ PPBS/ HbA1C
- Presence of atleast 1 FBS parameter measured in the past 6-18 months which was not > 125 mg/dl
- END-PDAC score > 2
Exclusion Criteria:
- Known or newly detected chronic pancreatitis
- Past history of pancreatic cancer
- History of steroid use
- Contraindications for EUS
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Incidence of PDAC at 3 years
Time Frame: 3yrs
|
3yrs
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
• Incidence of PDAC at baseline • Incidence of resectable PDAC at baseline • Incidence of resectable PDAC at 3 years
Time Frame: baseline and 3yrs
|
baseline and 3yrs
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PDAC-NOD-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatic Ductal Adenocarcinoma (PDAC)
-
Mayo ClinicRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | PDAC | PDAC - Pancreatic Ductal AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteRecruitingPancreatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreatic Neoplasm | PDAC | PDAC - Pancreatic Ductal AdenocarcinomaUnited States
-
Qilu Pharmaceutical Co., Ltd.Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)China
-
Azienda Ospedaliera Universitaria Integrata VeronaRecruitingPDAC - Pancreatic Ductal AdenocarcinomaItaly
-
Tianjin Medical University Cancer Institute and...Not yet recruitingPDAC - Pancreatic Ductal Adenocarcinoma
-
Sun Yat-sen UniversityRecruitingPDAC - Pancreatic Ductal AdenocarcinomaChina
-
Cedars-Sinai Medical CenterRecruitingPDAC - Pancreatic Ductal AdenocarcinomaUnited States
-
Qilu Hospital of Shandong UniversityCompletedPancreatic Ductal Adenocarcinoma (PDAC)China
-
Ruijin HospitalRecruitingPancreatic Ductal Adenocarcinoma, PDACChina
-
Ruijin HospitalRecruitingPancreatic Ductal Adenocarcinoma, PDACChina
Clinical Trials on A blood sample for CA 19-9 (cancer detection test)
-
National Jewish HealthCompletedHigh Risk of Developing Lung CancerUnited States
-
University of MiamiWithdrawnProstate Cancer | Prostate AdenocarcinomaUnited States
-
Guangzhou Institute of Respiratory DiseaseThe Fifth Affiliated Hospital of Zunyi Medical CollegeCompletedCOPD | Metabolomics | Omega 3 | Omega 6
-
Joslin Diabetes CenterActive, not recruiting
-
Sohag UniversityNot yet recruiting
-
Felix GutierrezHospital Clinic of Barcelona; Hospital General Universitario Elche; Germans Trias... and other collaboratorsRecruiting
-
Hospital do CoracaoBoehringer Ingelheim; Centro Rossi, Buenos Aires, ArgentinaRecruitingHypersensitivity PneumonitisArgentina, Brazil, Chile
-
Fred Hutchinson Cancer CenterNational Cord Blood NetworkRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Hematopoietic and Lymphoid System Neoplasm | Blastic Plasmacytoid Dendritic Cell Neoplasm | Myeloproliferative Neoplasm | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Chronic...United States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States